Literature DB >> 23467314

Survival of Alzheimer's disease patients in Korea.

Seok Min Go1, Kang Soo Lee, Sang Won Seo, Juhee Chin, Sue J Kang, So Young Moon, Duk L Na, Hae-Kwan Cheong.   

Abstract

BACKGROUND/AIMS: The natural history of Alzheimer's disease (AD) has rarely been studied in the Korean population. Our study on survival analyses in Korean AD patients potentially provides a basis for cross-cultural comparisons.
METHODS: We studied 724 consecutive patients from a memory disorder clinic in a tertiary hospital in Seoul, who were diagnosed as having AD between April 1995 and December 2005. Deaths were identified by the Statistics Korea database. The Kaplan-Meier method was used for survival analysis, and a Cox proportional hazard model was used to assess factors related to patient survival.
RESULTS: The overall median survival from the onset of first symptoms and from the time of diagnosis was 12.6 years (95% confidence interval 11.7-13.4) and 9.3 years (95% confidence interval 8.7-9.9), respectively. The age of onset, male gender, history of diabetes mellitus, lower Mini-Mental State Examination score, and higher Clinical Dementia Rating score were negatively associated with survival. There was a reversal of risk of AD between early-onset and later-onset AD, 9.1 years after onset.
CONCLUSIONS: The results of our study show a different pattern of survival compared to those studies carried out with western AD populations. Mortality risk of early-onset AD varied depending on the duration of follow-up.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23467314     DOI: 10.1159/000347133

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  4 in total

1.  Causes of Mortality in Korean Patients with Neurodegenerative Dementia.

Authors:  Hyo Geun Choi; Bumjung Park; Ji Hee Kim; Joo-Hee Kim; Mi Jung Kwon; Miyoung Kim
Journal:  Biomed Res Int       Date:  2022-04-25       Impact factor: 3.246

2.  Blood cadmium levels and Alzheimer's disease mortality risk in older US adults.

Authors:  Jin-Young Min; Kyoung-Bok Min
Journal:  Environ Health       Date:  2016-06-14       Impact factor: 5.984

Review 3.  Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region.

Authors:  Marwan Sabbagh; SeolHeui Han; SangYun Kim; Hae-Ri Na; Jae-Hong Lee; Nagaendran Kandiah; Kammant Phanthumchinda; Chuthamanee Suthisisang; Vorapun Senanarong; Ming-Chyi Pai; Diatri Narilastri; Ajit M Sowani; Encarnita Ampil; Amitabh Dash
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-09-09

4.  Survival Analysis of Patients with Alzheimer's Disease: A Study Based on Data from the Korean National Health Insurance Services' Senior Cohort Database.

Authors:  Tae Ho Huh; Jong Lull Yoon; Jung Jin Cho; Mee Young Kim; Young Soo Ju
Journal:  Korean J Fam Med       Date:  2020-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.